VIRAL HEPATITIS
Clinical trials for VIRAL HEPATITIS explained in plain language.
Never miss a new study
Get alerted when new VIRAL HEPATITIS trials appear
Sign up with your email to follow new studies for VIRAL HEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hepatitis b drug showdown: which is safer for kidneys?
Disease control Recruiting nowThis study compares two antiviral drugs, tenofovir alafenamide (TAF) and entecavir, in 140 adults with chronic hepatitis B. The goal is to see which one controls the virus better and causes fewer kidney problems. Participants take one pill daily for about a year.
Matched conditions: VIRAL HEPATITIS
Phase: PHASE4 • Sponsor: Taichung Veterans General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug combo aims to tackle stubborn hepatitis d
Disease control Recruiting nowThis Phase 3 trial tests whether a combination of two drugs, tobevibart and elebsiran, can suppress hepatitis D virus in adults who are still infected despite taking bulevirtide. About 150 participants will receive the combo as injections. The main goal is to see if the virus bec…
Matched conditions: VIRAL HEPATITIS
Phase: PHASE3 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC